Moloney Securities Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-18,800
Closed -$1.09M 521
2024
Q3
$1.09M Buy
+18,800
New +$924K 0.15% 171

Other funds holding ASTH

Moloney Securities Asset Management's ASTH Position: Q4 2024 in Review

Moloney Securities Asset Management sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 18,800 shares — an estimated $1.09M sold.

Moloney Securities Asset Management first reported a position in ASTH in Q3 2024 and held it in 1 quarter. The position peaked at $1.09M in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Moloney Securities Asset Management reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Moloney Securities Asset Management sold 18,800 Astrana Health shares in Q4 2024, an estimated $1.09M.
  • Moloney Securities Asset Management first reported a position in Astrana Health in Q3 2024 and held it in 1 quarter.
  • Moloney Securities Asset Management's Astrana Health position peaked at $1.09M in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Moloney Securities Asset Management's 13F filing for Q4 2024, filed 28 Jan 2025.